Ali H El-Far Selected Research

Ali H El-Far Research Topics

Disease

18	Neoplasms (Cancer) 10/2023 - 01/2020
7	Breast Neoplasms (Breast Cancer) 12/2022 - 09/2018
5	Inflammation (Inflammations) 04/2024 - 09/2018
5	Body Weight (Weight, Body) 01/2024 - 01/2020
4	Liver Neoplasms (Liver Cancer) 04/2024 - 01/2022
3	B-Cell Lymphoma (Lymphoma, B Cell) 08/2021 - 01/2021
3	Wounds and Injuries (Trauma) 04/2021 - 01/2020
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2015
2	Cardiotoxicity 10/2023 - 06/2021
2	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 09/2023
2	Stomach Ulcer (Gastric Ulcer) 11/2021 - 01/2018
2	Carcinogenesis 06/2021 - 05/2020
2	Cardiomyopathies (Cardiomyopathy) 06/2020 - 01/2018
2	Diabetes Mellitus 05/2020 - 04/2017
2	Colonic Neoplasms (Colon Cancer) 03/2020 - 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2024
1	Ascites 10/2023
1	Carcinoma (Carcinomatosis) 10/2023
1	Triple Negative Breast Neoplasms 03/2023
1	Acute Lung Injury 12/2021
1	Ulcer 11/2021
1	Lung Injury 01/2021
1	Hyperthermia 10/2020
1	Heart Failure 06/2020
1	Weight Loss (Weight Reduction) 06/2020
1	Colorectal Neoplasms (Colorectal Cancer) 03/2020

Drug/Important Bio-Agent (IBA)

10	thymoquinoneIBA 03/2023 - 01/2015
8	AntioxidantsIBA 01/2024 - 04/2017
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 09/2018
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2021
3	Sorafenib (BAY 43-9006)FDA Link 10/2023 - 03/2023
3	CurcuminIBA 01/2022 - 01/2020
3	QuercetinIBA 04/2021 - 06/2020
3	Caspase 3 (Caspase-3)IBA 04/2021 - 11/2018
2	Matrix Metalloproteinases (MMPs)IBA 04/2024 - 05/2020
2	CytokinesIBA 04/2024 - 01/2018
2	EnzymesIBA 10/2023 - 08/2022
2	Ethanol (Ethyl Alcohol)IBA 11/2021 - 01/2018
2	costunolideIBA 08/2021 - 01/2021
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 03/2020
2	Oxidants (Oxidizing Agents)IBA 11/2018 - 01/2018
1	SilverIBA 04/2024
1	fenpropathrinIBA 01/2024
1	Nicotine FDA Link 10/2023
1	DiarylheptanoidsIBA 10/2023
1	CholesterolIBA 10/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2023
1	cypermethrin (alphamethrin)IBA 10/2023
1	Glutathione (Reduced Glutathione)IBA 10/2023
1	Amygdalin (Laetrile)IBA 09/2023
1	piperineIBA 03/2023
1	Antimitotic AgentsIBA 01/2023
1	Adenosine (Adenocard)FDA LinkGeneric 01/2023
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2023
1	Pyruvate KinaseIBA 08/2022
1	IsoflavonesIBA 12/2021
1	myrrh resin (myrrh)IBA 11/2021
1	myrrh oilIBA 11/2021
1	Periodic AcidIBA 11/2021
1	Multidrug Resistance-Associated ProteinsIBA 09/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 06/2021
1	IronIBA 04/2021
1	AcetylcholinesteraseIBA 04/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 04/2021
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2021
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2021
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	pycnogenolsIBA 10/2020
1	Saline SolutionIBA 06/2020
1	Rutin (Rutoside)IBA 06/2020
1	Troponin IIBA 06/2020
1	trans-crotonin (CTN)IBA 06/2020
1	Receptor for Advanced Glycation End ProductsIBA 05/2020
1	Advanced Glycation End ProductsIBA 05/2020
1	HMGB1 Protein (HMG1)IBA 05/2020
1	Mitogen-Activated Protein KinasesIBA 05/2020
1	Apoptosis Regulatory ProteinsIBA 05/2020
1	NF-kappa B (NF-kB)IBA 05/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 05/2020
1	LigandsIBA 05/2020
1	TOR Serine-Threonine KinasesIBA 05/2020
1	Cisplatin (Platino)FDA LinkGeneric 03/2020
1	ResveratrolIBA 03/2020
1	polyethylene glycol-poly(lactic-co-glycolic acid)-polyethylene glycolIBA 01/2020
1	Antineoplastic Antibiotics (Cytotoxic Antibiotics)IBA 01/2020
1	Alkylating AgentsIBA 01/2020
1	GlucansIBA 01/2020
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2020
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2020
1	AntimetabolitesIBA 01/2020
1	Topoisomerase InhibitorsIBA 01/2020
1	Drinking WaterIBA 01/2020

Therapy/Procedure

8	Therapeutics 01/2023 - 01/2020
3	Drug Therapy (Chemotherapy) 09/2021 - 01/2020
2	Immunotherapy 01/2023 - 09/2021
1	Injections 06/2020
1	Oral Administration 01/2020